| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/10/2003 | US20030129678 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 07/10/2003 | US20030129663 Methods and compositions for modulating oxidized ldl transport |
| 07/10/2003 | US20030129655 Nucleic acids encoding GTPase activating proteins |
| 07/10/2003 | US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 07/10/2003 | US20030129586 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase. |
| 07/10/2003 | US20030129295 Comprises protective lipid coating (hydrogenated oils) for choline chloride or lysine hydrochloride; ruminant feeds |
| 07/10/2003 | US20030129294 Hydroquinone-substituted fatty acid for use in foods; lipase inhibitors; peroxisome proliferator activated receptors; antiaging agents |
| 07/10/2003 | US20030129269 Extracts of cacao and cacao bean husk with inhibitory effects on carcinogenesis |
| 07/10/2003 | US20030129268 Use of at least a fatty ester for preparing a composition designed to inhibit 5-$g(a)-reductase activity, in pharmacology, in particular dematology, in cosmetics and as food additive |
| 07/10/2003 | US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier |
| 07/10/2003 | US20030129237 Multiparticulate modified release composition |
| 07/10/2003 | US20030129235 Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
| 07/10/2003 | US20030129193 Comprises antibody-coagulant constructs (coaguligands) for induction of (drug resistant) tumor thrombosis/necrosis |
| 07/10/2003 | US20030129188 Peptide mimetics; catalytic antibodies such as aldolase, beta-lactamase, esterase, or amidase; for treatment of angiogenesis, bone metabolism disorders, inflammation, or cell growth disorders |
| 07/10/2003 | US20030129186 Compositions and methods for modulating blood-brain barrier transport |
| 07/10/2003 | US20030129181 Hydrolases modified by polyoxyethylene glycol for induction of high plasmatic levels of free tumor necrosis factor |
| 07/10/2003 | US20030129176 Atherosclerosis-associated genes |
| 07/10/2003 | US20030129161 Interleukin-12 as a veterinary vaccine adjuvant |
| 07/10/2003 | US20030129150 Cosmetic preparations containing plant extracts |
| 07/10/2003 | US20030129129 Prevention, therapy disease; forming tritiated water; calibration |
| 07/10/2003 | US20030127621 Kinesin motor modulators derived from the marine sponge adocia |
| 07/10/2003 | CA2482392A1 Carboxylic acid derivative |
| 07/10/2003 | CA2472121A1 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof |
| 07/10/2003 | CA2471713A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 07/10/2003 | CA2471679A1 Negatively charged polysaccharide derivable from aloe vera |
| 07/10/2003 | CA2471635A1 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 07/10/2003 | CA2471531A1 Agents for treating mild cognitive impairment |
| 07/10/2003 | CA2471348A1 Quinazolinone derivative |
| 07/10/2003 | CA2471306A1 Secreted proteins |
| 07/10/2003 | CA2471300A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std) |
| 07/10/2003 | CA2471297A1 Human netrin receptor and uses thereof |
| 07/10/2003 | CA2471236A1 Urea derivatives |
| 07/10/2003 | CA2471217A1 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 07/10/2003 | CA2471130A1 Il-17 like molecules and uses thereof |
| 07/10/2003 | CA2471049A1 Amide derivatives as gk activators |
| 07/10/2003 | CA2470666A1 Secreted protein |
| 07/10/2003 | CA2469967A1 Urea derivatives as vr1- antagonists |
| 07/10/2003 | CA2467337A1 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 07/10/2003 | CA2463143A1 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 07/09/2003 | EP1325930A1 Mammal prolactin variants |
| 07/09/2003 | EP1325921A2 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators |
| 07/09/2003 | EP1325920A1 N-substituted benzothiophenesulfonamide derivatives |
| 07/09/2003 | EP1325918A1 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| 07/09/2003 | EP1325917A1 Radiolabelled alkylamino-benzothiazole and -benzoxazole derivatives and their use as D4 ligands |
| 07/09/2003 | EP1325910A1 Aliphatic nitrogenous five-membered ring compounds |
| 07/09/2003 | EP1325909A1 Tricyclic indole compounds having affinity for serotonin receptor |
| 07/09/2003 | EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 07/09/2003 | EP1325751A1 Novel drugs for liver diseases |
| 07/09/2003 | EP1325745A1 Preventives and remedies for complications of diabetes |
| 07/09/2003 | EP1325682A1 Food or pet food composition containing plant extracts for maintenance of bone health and prevention or treatment of bone diseases |
| 07/09/2003 | EP1325341A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins |
| 07/09/2003 | EP1325324A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 07/09/2003 | EP1325144A2 Chromosomal vectors and uses thereof |
| 07/09/2003 | EP1325137A2 Truncated phosphodiesterase-7 polypeptides |
| 07/09/2003 | EP1325124A2 Clk-2, cex-7 and coq-4 genes, and uses thereof |
| 07/09/2003 | EP1325117A2 Lipid metabolism enzymes |
| 07/09/2003 | EP1325030A2 Genes isolated from dendritic cells, gene products and methods employing the same |
| 07/09/2003 | EP1325028A2 New inhibitors of iapp fibril formation and uses thereof |
| 07/09/2003 | EP1325025A1 Peptide-based gemini surfactant compounds facilitating the transfer into cells |
| 07/09/2003 | EP1325019A1 Antisense modulation of clusterin expression |
| 07/09/2003 | EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 07/09/2003 | EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 07/09/2003 | EP1325006A2 Heterocyclic compounds as ligands of the gaba a? receptor |
| 07/09/2003 | EP1325004A1 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 07/09/2003 | EP1325001A1 Anticholinergic agents that can be used as medicaments and method for the production thereof |
| 07/09/2003 | EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 07/09/2003 | EP1324998A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 07/09/2003 | EP1324997A2 Dioxolane analogs for improved inter-cellular delivery |
| 07/09/2003 | EP1324994A2 Tricyclic compounds and uses thereof |
| 07/09/2003 | EP1324991A1 Compounds useful in the treatment of inflammatory diseases |
| 07/09/2003 | EP1324986A1 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 07/09/2003 | EP1324985A1 Inhibitors of prenyl-protein transferase |
| 07/09/2003 | EP1324981A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 07/09/2003 | EP1324980A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 07/09/2003 | EP1324972A1 Dihydroxy open-acid salt of simvastatin |
| 07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
| 07/09/2003 | EP1324778A2 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 07/09/2003 | EP1324774A2 Use of a ppar delta activator for treating inflammatory conditions |
| 07/09/2003 | EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition |
| 07/09/2003 | EP1324772A2 Methods for treating disorders of the female reproductive system |
| 07/09/2003 | EP1324767A2 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 07/09/2003 | EP1324766A2 Methods and compositions for the treatment of peripheral artery disease |
| 07/09/2003 | EP1324760A1 Creatine ester pronutrient compounds and formulations |
| 07/09/2003 | EP1324759A2 Nf-g(k)b inhibitors |
| 07/09/2003 | EP1324757A1 Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease |
| 07/09/2003 | EP1324652A2 Transgenic drosophila melanogaster expressing beta amyloid |
| 07/09/2003 | EP1235810B1 Process of making substituted pyrazoles |
| 07/09/2003 | EP1164140B1 Novel sulfofucosylacylglycerol derivatives and utilization thereof as drugs |
| 07/09/2003 | EP1164139B1 Novel sulforhamnosylacylglycerol derivatives and use thereof as medicaments |
| 07/09/2003 | EP1040096B1 Neuroprotective agents |
| 07/09/2003 | EP0988316A4 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 07/09/2003 | EP0988306B1 3-substituted 3,4 dihydro-thieno 2, 3-d]pyrimidine derivatives and production and use of the same |
| 07/09/2003 | EP0983262B1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
| 07/09/2003 | EP0966465B1 Inhibitors of impdh enzyme |
| 07/09/2003 | EP0948500B1 Cyclic organoselenium compounds, their preparation and their uses |
| 07/09/2003 | EP0912558B1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 07/09/2003 | EP0888353B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE |
| 07/09/2003 | EP0823906B1 Piperazino derivatives as neurokinin antagonists |
| 07/09/2003 | EP0788307B1 Oligonucleotide modulation of the expression of multidrug resistance-associated protein |
| 07/09/2003 | EP0686194B1 Harp family growth factors, preparation methods therefor and uses thereof |